InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Smith Mary L., Director. Officer active across 1 company, notably PTC Therapeutics, INC.. In total, 10 filings have been recorded. Split: 0 buy · 2 sells. Total volume traded: €1.2m. Activity tracked since 11 June 2021. The latest transaction was disclosed on 9 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Smith Mary L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
10,000 shares@ US$42.950.0061% mcap12.2% of flowCommon StockSEC:0001866044-26-000005:0
10,000 shares@ US$90.000.013% mcap25.5% of flowCommon StockSEC:0001866044-26-000005:1
5,834 shares@ US$42.950.0035% mcap7.1% of flowCommon StockSEC:0001866044-26-000005:2
5,834 shares@ US$90.000.0074% mcap14.9% of flowCommon StockSEC:0001866044-26-000005:3
4,000 shares0Common StockSEC:0001866044-26-000003:0
4,000 shares0Common StockSEC:0001415889-25-001026:0
4,000 shares0Common StockSEC:0001415889-24-004098:0
4,000 shares0Common StockSEC:0001415889-23-000668:0
3,200 shares0Common StockSEC:0001179110-22-000393:0
1,650 shares0Common StockSEC:0001179110-21-006723:0
10 of 10 declarations
About Smith Mary L.
Smith Mary L. is Administrateur at PTC Therapeutics, INC. (XNAS). She has 10 filings in total, and across the 10 sampled filings from 2021-06-15 to 2026-07-13, sales amount to EUR 1247070 and purchases to EUR 0, with the modal transaction nature listed as Attribution.
